Home›Companies›Biotech & Pharma›Ionetix

Ionetix Corp

Updated Oct 29, 2026·Latest SEC filing Aug 26, 2024·Suggest an edit

About Ionetix

Ionetix is a private company based in Lansing, Michigan. It has reported $61,083,539 raised in three offerings on Form D since April 2016.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 9, 2024Aug 26, 2024$0of $15.4M target0—OptionsRule 506(b)Form D ↗
Dec 14, 2018Dec 21, 2018amended May 6, 2020$37,288,167of $42.9M target24$1.5MEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 15, 2016Apr 27, 2016amended Mar 12, 2018$23,795,372of $25.3M target46$517KEquityRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$61,083,539

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Ionetix's Form D filed Aug 26, 2024.

DM
David Martin
Director
AS
Anthony Stagnolia
Executive officer
DE
David Eve
Executive officer
DB
GT
PP
Phun Phieu
Executive officer
MT
GM
KC
Kevin Cameron
Executive officer and director

Earlier filings also listed Nancy Hargreaves (chief financial officer, last listed May 2020), Michael Tarnock (director, last listed May 2020) and Carrie Busch (vp, finance, last listed Mar 2018).

Sources

  1. SECIonetix Corp Form D, filed Dec 21, 2018
  2. SECIonetix Corp Form D, filed Apr 27, 2016
  3. SECIonetix Corp filing history